InnoCare Pharma Limited (SHA:688428)
China
· Delayed Price · Currency is CNY 24.99
+0.15 (0.60%)
At close: Dec 5, 2025
InnoCare Pharma Market Cap
InnoCare Pharma has a market cap or net worth of 25.32 billion as of December 5, 2025. Its market cap has increased by 102.06% in one year.
Market Cap
25.32B
Enterprise Value
20.02B
Revenue
1.43B
Ranking
n/a
PE Ratio
n/a
Stock Price
24.99
Market Cap Chart
Since March 23, 2020, InnoCare Pharma's market cap has increased from 11.23B to 25.32B, an increase of 125.59%. That is a compound annual growth rate of 15.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 25.32B | 120.53% |
| Dec 31, 2024 | 11.48B | -3.51% |
| Dec 29, 2023 | 11.90B | -42.63% |
| Dec 30, 2022 | 20.74B | 20.72% |
| Dec 31, 2021 | 17.18B | 17.44% |
| Dec 31, 2020 | 14.63B | 30.36% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 407.03B |
| WuXi AppTec | 269.55B |
| Shenzhen Mindray Bio-Medical Electronics | 244.77B |
| Sichuan Biokin Pharmaceutical | 150.71B |
| Shanghai United Imaging Healthcare | 105.68B |
| Aier Eye Hospital Group | 105.04B |
| Zhangzhou Pientzehuang Pharmaceutical., | 101.93B |
| Yunnan Baiyao Group Co.,Ltd | 99.79B |